Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01958112
Title GSK1120212+GSK2141795 for Cervical Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

cervical cancer

Therapies

Trametinib + Uprosertib

Age Groups: adult
Covered Countries USA


No variant requirements are available.